French study finds anti-malarial/antibiotic combo could reduce Covid-19 duration

techcrunch.com

1 pointcoldcode2 comments

The control group is not randomized, and most of it is in another(s) hospital(s).

They are not counting the 6 patients that they lost in the treatment group (2 leave, 3 where transfer to ICU, 1 die). It is more strange that they didn't lost any patient in the control group.

It's strange that they use an antibiotic against a viral infection.

More discussion in https://news.ycombinator.com/item?id=22624955

There definitely needs to be more randomized trials regarding hydroxychloroquine. It can have adverse side-effects on the eyes and/or kidneys. It is not a benign compound.

Reply on news.ycombinator.com